Literature DB >> 10741394

Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis.

T Suter1, U Malipiero, L Otten, B Ludewig, A Muelethaler-Mottet, B Mach, W Reith, A Fontana.   

Abstract

In the normal central nervous system (CNS) expression of MHC class II is minimal, but has been found to be highly up-regulated on microglia cells in experimental autoimmune encephalitis (EAE). Here we used the EAE model to examine the regulation of expression of the class II transactivator (CIITA), which is required for activation of MHC class II genes. EAE was induced in C57BL/6 mice by immunization with myelin oligodendrocyte glycoprotein peptide 35-55. CIITA mRNA form I (specific for dendritic cells) and form IV (IFN-gamma inducible) but not form III (B cell specific) were detected in brain and spinal cord of mice with acute EAE. In unimmunized or mock-immunized mice, none of the three CIITA forms was found to be induced. Dendritic cells (DC) were identified by immunostainings for CD11c in perivascular and meningeal cell infiltrates in EAE spinal cord and brain. Time-course analysis showed (1) the appearance of DC in the CNS shortly before onset of disease, (2) the recruitment of CD11b cells occuring much earlier and (3) the absence of CIITA and MHC class II expression in these CD11b+ cells at preclinical stages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741394     DOI: 10.1002/1521-4141(200003)30:3<794::AID-IMMU794>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.

Authors:  M Pashenkov; N Teleshova; M Kouwenhoven; V Kostulas; Y-M Huang; M Soderstrom; H Link
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

Review 2.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 3.  Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS.

Authors:  Benjamin D Clarkson; Erika Héninger; Melissa G Harris; JangEun Lee; Matyas Sandor; Zsuzsanna Fabry
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.

Authors:  Doina Ganea; Virginia Kocieda; Weimin Kong; Jui-Hung Yen
Journal:  Clin Lipidol       Date:  2011-06

Review 5.  Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity.

Authors:  Ari Waisman; Lisa Johann
Journal:  J Mol Med (Berl)       Date:  2018-11-01       Impact factor: 4.599

6.  Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis.

Authors:  B Serafini; S Columba-Cabezas; F Di Rosa; F Aloisi
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 7.  Glial grafting for demyelinating disease.

Authors:  V Tepavcević; W F Blakemore
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

8.  Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells.

Authors:  M Pashenkov; M Söderström; Y-M Huang; H Link
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

9.  MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.

Authors:  Magali Irla; Natalia Küpfer; Tobias Suter; Rami Lissilaa; Mahdia Benkhoucha; Jonathan Skupsky; Patrice H Lalive; Adriano Fontana; Walter Reith; Stéphanie Hugues
Journal:  J Exp Med       Date:  2010-08-09       Impact factor: 14.307

10.  Patterned variation in murine MHC promoters.

Authors:  N Avrion Mitchison; Jurgen Roes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.